IFNG and neoplasm: Several other markers have been reported as predicative for ICI efficacy, including the composition of peripheral blood leukocytes, circulating tumor DNA (ctDNA) and exosomes, tumor mutational burden (TMB), high interferon-gamma-related gene expression signature in tumors, as well as the diversity of the gut microbiome [20,21,22,23,24,25,26,27].